Healthcare Distribution Alliance – Patients Move Us.
Share Print


IPDC | 16–17 Oct. 2017 | Geneva, Switzerland


Ronan Brett  
Ronan Brett, Group Public Affairs Director, McKesson Europe AG

Ronan Brett is a qualified pharmacist and a public affairs professional. Over the years, he has worked in a broad range of healthcare settings at board and executive level. He currently leads Celesio’s Group Public Affairs team in Stuttgart. His function is responsible for the development of the group’s overall public affairs strategy including all Public Affairs, Pharmacy and Distribution Trade body relations, sector issue and policy risk management and public policy activity. His team provides consultancy support to all Celesio Group Businesses on a range of topics, including: corporate public policy, remuneration support, strategic development, issue management, regulatory assessment and market analysis, to our country management teams, group directors and to the Celesio management board.

Ronan worked as a front-line pharmacist until 2003. He then took on more senior management roles including NHS healthcare services development and working as a healthcare lobbyist in the U.K., Germany and more recently, he established, staffed and managed Celesio’s Brussels office.

Being a qualified healthcare professional and a senior public affairs executive has given Ronan a unique insight and understanding of health policy and politics. He has built up a broad range of contacts at local, national, EU and international level.

John Quentin Dittman  
John Quentin Dittman, Director, Sustain and Track & Trace, Cardinal Health, Inc.

John Quentin Dittman is Director of Operations Technology at Cardinal Health, a position he has held since January of 2016. In this role, he is responsible for transforming the Pharmaceutical segment by leveraging technology and lean processes to deliver agility and flexibility in an ever changing environment. Quentin is also responsible for optimizing the Pharmaceutical Distribution supply chain in response to the Federal Drug Supply Chain Security Act of 2013 (DSCSA).

Prior to this role, Quentin was Manager of Operational Excellence, a Lean Six Sigma Black Belt supporting numerous teams such as Cardinal Health Repackaging Solutions, National Accounts and Sales Operations teams.

Quentin also served as a Senior Consultant in Operations Technology for both the Pharmaceutical and Medical business units.

Quentin began his career at Accel Inc., a contract packager where he held roles in inventory, information technology and operations.

Quentin holds a Bachelor’s of Art in History and a Master’s in Business Administration from The Ohio State University .

Maggie Dolan  
Maggie Dolan, Specialist Procurement Pharmacist, NHS Commercial Solutions

Maggie Dolan has many years of experience as a hospital clinical pharmacist primarily in Scotland. She was Chief Pharmacist in Edinburgh in both the adult (West Lothian NHS Trust) and pediatric (Edinburgh sick Children’s Hospital) settings over the period of 1993–2005.

Throughout her career, Maggie has developed a keen interest in the safe, effective and cost-effective procurement of medicines to the benefit of both individual patients and the NHS economy. She currently serves as Regional Medicine Procurement Specialist for the South East Coast of England. With the emergent role of biosimilars in therapy in the U.K., she has embraced the challenge of the introduction of biosimilars in the NHS in England. She is a member of the NHS England Biosimilar Project board and chairs the NHS Biosimilars Group.

Maggie achieved her B.Sc. Pharmacy at Heriot Watt University, Edinburgh, and a diploma in clinical pharmacy from Strathclyde University.

Greg Drew  
Greg A. Drew, RPh, President, Value Drug Company

Greg Drew is President of Value Drug Company, a regional, co-operatively owned pharmaceutical distributor operating out of Altoona, Pennsylvania. Value Drug Company is a full-line wholesale distributor operating in eight states. Greg is a Pharmacist by training; however, he has been in various pharmaceutical related business leadership roles for the past 20 years, including chain pharmacy, pharmacy benefit management, academia, and for the last eight years, pharmaceutical distribution and logistics.

Greg is a member of the Healthcare Distribution Alliance (HDA) Executive Committee; Vice-Chairman of the HDA Research Foundation; a member of the Operating Committee for Optisource, a generic buying coalition; Vice Chairman of the Wholesale Alliance, LLC; and holds an Adjunct Associate Professorship of Pharmacy and Therapeutics at the University of Pittsburgh School of Pharmacy.

Greg also serves on various community and professional boards.

Perry Fri  
Perry L. Fri, Executive Vice President, Industry Relations, Membership & Education and COO, HDA Research Foundation, Healthcare Distribution Alliance

Perry L. Fri is HDA’s Executive Vice President of Industry Relations, Membership & Education and Chief Operating Officer of the HDA Research Foundation. At HDA, Fri is responsible for the direction, supervision and development of industry initiatives that facilitate improved business processes and operational efficiencies in the healthcare supply chain. Fri currently serves on the Board of Directors for Healthcare Ready, a 501(c)(3) organization established to help public and private sector stakeholders across the pharmaceutical supply chain prepare for (and maintain operations during) disasters.

Fri most recently served as Vice President of Industry Relations and Program Development for the Health Industry Distributors Association (HIDA). Prior to joining HIDA, Fri was a consultant for The Hale Group. He also was Vice President of Industry Alliances for Instill Corporation, and was the Director of Supply Chain Management for NWDA (now HDA). He holds a BA in History from the University of Maryland.

Jon Giacomin  
Jon L. Giacomin,

Jon Giacomin is the chief executive officer of the Pharmaceutical Segment of Cardinal Health which delivers approximately 25 percent of all medications prescribed in the U.S. each day. The $109.1 billion Pharmaceutical Segment is comprised of 16 businesses that offer a range of services across the entire healthcare supply chain. At the core, these businesses ensure that branded, generic and specialty pharmaceuticals are delivered to retail pharmacies, hospitals, mail-order facilities, physician offices, surgery centers and long-term and other alternate care facilities. Additionally, these businesses provide a range of critical services such as inventory management, marketing, nuclear compounding, drug manufacturing, reimbursement consulting, FDA consulting, clinical pathways programs and third-party logistics allowing customers to focus on what matters most – patients.

Prior to his current role, Giacomin was the president of U.S. Pharmaceutical Distribution, where he was responsible for the business consolidating pharmaceuticals from hundreds of manufacturers into site-specific deliveries to health care points of care. Previously, Giacomin was the executive vice president of Pharmaceutical Operations, where he was responsible for efficient and responsive warehouse operations at 22 distribution centers and pharmaceutical repackaging operations. He also held the role of senior vice president of inventory management for the Healthcare Supply Chain Services segment, a role he assumed after his tenure as regional vice president and general manager for the Pacific Northwest region of the company’s Pharmaceutical Distribution business. Giacomin joined Cardinal Health in 2001 as vice president and general manager of its Pharmaceutical Repackaging business.

Prior to joining Cardinal Health, Giacomin held engineering roles with Griffith Micro Science, Sterigenics and the U.S. Navy.

Giacomin currently serves on the Cardinal Health Foundation Board and as the executive sponsor of the Cardinal Health Veterans and Military Advocates employee resource group. He is a member of the executive committee and serves as Chairman of the board of directors for the Healthcare Distribution Alliance and serves on the board of directors for the National Association of Chain Drug Stores.

He earned a bachelor’s degree in mechanical engineering from the University of Notre Dame and a master of business administration from the University of Chicago.

John Gray  
John M. Gray,

John M. Gray has served as the President and Chief Executive Officer of HDA since 2004. He is responsible for overseeing all HDA operations and activities and reports directly to the HDA Board of Directors. Gray also serves as President and CEO of the HDA Research Foundation.

Prior to joining HDA, Gray served for eight years as Food Distributor International’s (FDI) Executive Vice President and General Counsel. When FDI merged with the Food Marketing Institute to form the International Foodservice Distributors Association in 2003, Gray became its President and CEO.

From 1987 to 1994, Gray served as Vice President of Education and as Industry Affairs Counsel for the Grocery Manufacturers Association.

Gray holds an AB from The College of William & Mary; an MBA from the Wharton School, University of Pennsylvania; and a JD from the University of Virginia School of Law.

Fumie Griego  
Fumie Griego, Ph.D., Assistant Director General, International Federation of Pharmaceutical Manufacturers & Associations (IFPMA)

Fumie Griego is Assistant Director General for Strategic Planning, Policy and Research. Fumie leads IFPMA’s work on health economics and policy such as value of medicines, pricing and reimbursement, and metrics/evaluation. Prior to joining IFPMA, Fumie was Head of Global Oncology Policy and Strategy, Global Government Affairs & Policy at Merck KGaA and Vice President for International Health Policy at Pharmaceutical Research and Manufacturers of America (PhRMA). Prior to joining PhRMA, Fumie was a senior economist in the White House’s Office of Management and Budget where she provided U.S. senior officials with policy advice on a range of health policy issues in both the Bush and Obama administrations.

Fumie holds a Ph.D. in Health Policy from Harvard University and a Bachelor and Master of Science degrees in Earth Systems (concentration in environmental economics and policy) from Stanford University.

Jason Hanks  
Jason A. Hanks, Chief Commercial Officer, Granules Pharmaceuticals

Jason Hanks, Senior Vice President of Product Strategy and Supplier Partnerships of U.S. Pharmaceuticals, has been in his current role since October 2016. Hanks is responsible for McKesson’s Brand, Specialty and Packaging sourcing operations, as well as development and growth of supplier partnerships.

Prior to his current role, Hanks was McKesson’s Vice President of Generics Sourcing since 2011 and was responsible for generic purchasing in the U.S. Pharmaceutical, McKesson Specialty and McKesson Medical-Surgical divisions.

Hanks joined McKesson in 2002 as the Senior Director of Pricing and Business Development and was later promoted to Vice President. In that role, he directed all pricing activity in the Independent Small/ Medium Chains Segment, Retail National Accounts and Health Care Solutions. In this role, he was a key contributor to obtaining the contract for the Veterans Administration, the nation’s single largest healthcare provider contract, as well as helping to develop and launch OneStop program for hospital customers. Before joining McKesson, Hanks held several finance management positions.

Hanks holds an MBA from Golden Gate University, with an emphasis in International Management. He holds a B.S. degree from California State University, Chico in Business Administration, with an emphasis in Finance.

Scott Hussey  
Scott Hussey, Senior Vice President, Global Sales, Upsher-Smith Laboratories, LLC

Patrick Kelly  
Patrick M. Kelly, Executive Vice President, Government Affairs, Healthcare Distribution Alliance

As HDA’s Executive Vice President of Government Affairs, Patrick M. Kelly oversees all of HDA’s state and federal legislative, regulatory and political activities. Kelly sets strategic direction for the healthcare distribution industry’s advocacy agenda and leads the development of legislative and regulatory strategies to affect outcomes on priority issues. He also establishes and maintains relationships with members of Congress, and directs the prioritization of HDA positions on legislative and regulatory issues through the association’s task forces, committees and the Public Policy Council.

Prior to HDA, Kelly spent 16 years with the Biotechnology Industry Organization (BIO) as Vice President of State Government Relations and Alliance Development. Kelly began his professional career at the Grocery Manufacturers Association as a Representative for State Government Affairs. Kelly graduated from the University of Maryland with a degree in Government and Politics.

Douglas Long  
Douglas M. Long, Vice President, Industry Relations, IQVIA

Doug Long’s dedication and leadership in healthcare spans four decades. Doug has unparalleled experience and perspective on pharmaceutical distribution and the changing U.S. and global healthcare marketplace.

As Vice President of Industry Relations for IQVIA (formerly QuintilesIMS) – the world’s largest pharmaceutical information company – Doug has been a leader with the company since 1989 in implementing health databases, developing new products and fostering relationships with distributors, manufacturers, retailers and industry associations.

Doug’s annual Industry Year in Review showcases his unique perspective on a range of vital pharmaceutical topics, including global market trends, industry forecasts, research and development, marketing practices, blockbuster drugs, patent expirations and generic trends and biotechnology.

Wholesalers, retailers, manufacturers and healthcare trade associations rely on him for guidance, direction and industry expertise. Doug is a highly sought-after industry speaker at healthcare association and trade meetings. He also serves as a permanent member of the Editorial Advisory Board of HealthCare Distributor magazine.

Doug is the recipient of several industry achievement awards –the IFPW (International Federation of Pharmaceutical Wholesalers)  Leadership award (2016), the Harold W. Pratt Award, bestowed by the National Association of Chain Drug Stores (2012); the Nexus Award for Lifetime Achievement by the Healthcare Distribution Management Association (2004); and, IMS Health’s prestigious Summit Award (2003) and the Chinese Association of Pharmaceutical Commerce 2017 Award for his contributions to the Chinese Supply Chain.

Prior to IQVIA, Doug was at Nielsen Market Research for 16 years in sales and marketing capacities. A native of Illinois, Doug received a BA from DePauw University and an MBA from Fairleigh Dickinson University.

Pablo Medina  
Pablo Medina, Associate Director, Product Lifecycle and Protection, Genentech, A Member of the Roche Group

Pablo Medina is the Head of U.S. Product Lifecycle and Protection for Genentech, a member of the Roche Group. Based in San Francisco, California, he is responsible for managing Lifecyle events in the trade channel as well as leading various efforts to enhance Genentech’s product security including counterfeit, diversion, serialization and traceability. Prior to this, Pablo was the Head of Contract Manufacturing Supply Chain for the North America region where he was responsible for the implementation of serialization at contract manufacturers. While at Roche, he also held roles in supply chain as Global Project Manager in Basel and in Latin America where he was responsible for the implementation of S&OP and Regional Planning processes in Latin America affiliates. He brings over 10 years of experience in pharmaceutical supply chain in the U.S., Europe and Latin America.

Kaspar Niklaus  
Kaspar Niklaus, Managing Director, Amedis-UE AG

Kaspar Niklaus is Managing Director of Amedis-UE group (member of PHOENIXgroup Germany) and a Member of different boards of the PHOENIX Swiss Subgroup. At Amedis, he is responsible for the sales and marketing activities in the wholesale business.

In his former professional activities he acted as CEO / COO in different companies. He also worked as a Junior Project Manager for McKinsey&Company in Switzerland.

Mr. Niklaus started his career as a Diplom Engineer Agronomist (Federal Institute of Technology Zurich) and holds an MBA and an MBI from Rotterdam School of Management, The Netherlands.

Jeffrey Rowland  
Jeffrey Rowland, Director, Global Operational Partnerships, Gavi, the Vaccine Alliance

With nearly 20 years of experience in engaging the private sector to address critical humanitarian and health challenges, Jeff Rowland today leads business relations for Gavi, the Vaccine Alliance, a public-private partnership that provides life-saving vaccines to the world’s neediest children in 73 developing countries.

Over the span of his career, Jeff has created and managed shared value and corporate social responsibility relationships with a wide range of partners, including the Boston Consulting Group, British Telecom (BT), Benetton, Citigroup, CNN, Comic Relief, TNT, Unilever and UPS. He joined Gavi from the UN World Food Program where he launched and led the organization’s corporate partnership program, having spent his first years there working in a variety of humanitarian response operations, including during the Sierra Leone civil war, the war in Kosovo and during major drought crises in southern Sudan and Ethiopia.

Jeff began his professional career as a reporter at The Washington Post in Washington, D.C. and Italy and then worked for a member company of the international marketing and communications conglomerate Omnicom. He received a master’s degree in international affairs and economics from Johns Hopkins University after receiving a bachelor’s degree in politics in a program that included two years in Paris, France and Rome, Italy.

Douglas Scheckelhoff  
Douglas J. Scheckelhoff, FASHP, RPh, MS, Senior Vice President, Office of Practice Advancement, American Society of Health-System Pharmacists (ASHP)

Doug Scheckelhoff is Senior Vice President of Practice Advancement at the American Society of Health-System Pharmacists in Bethesda. In this role, he provides leadership and coordination of ASHP initiatives and efforts addressing critical practice issues. He oversees the Center on Pharmacy Practice Advancement, the Center on Medication Safety and Quality, and the Center on Practice Development. He also coordinates ASHP international programs, services and consulting.

Prior to coming to ASHP, Doug was Director of Pharmacy at Children’s National Medical Center and also held leadership positions at the Ohio State University Medical Center and University of Kentucky Medical Center. He received his training and residency at the Ohio State University Medical Center.

Doug is a frequent speaker and leading voice on medication safety, practice advancement and best practices.

Sarah Thomas  
Sarah Thomas, MS, Managing Director, Deloitte Center for Health Solutions

Sarah Thomas is the managing director of the Deloitte Center for Health Solutions, part of Deloitte LLP’s Life Sciences and Health Care practice. As the leader of the Center, she drives the research agenda to inform stakeholders across the health care landscape about key trends and issues facing the industry. Market and policy forces include the shift from a volume-based system to one more focused on cost and quality outcomes, the rise in consumerism and changes coming from new political leadership. Sarah aims for the Center to be a source of clarity for consumers, businesses, governments and other stakeholders. She has deep experience in public policy – ranging from reimbursement to quality issues in Medicare, Medicaid and the private health insurance market, including health insurance exchanges and marketplaces.

Sarah was previously vice president for public policy and communications at the National Committee for Quality Assurance (NCQA), where she was responsible for the development of NCQA’s public policy strategy, its work with the federal and state government, as well as its media and communications operations. She also served as the director of the Public Policy Institute (PPI) Health Team at AARP. She oversaw AARP’s advocacy in areas of cost, access and quality related to health care reform, Medicare, Medicaid, prescription drugs, private insurance and public health.

In addition to her nonprofit work, Sarah has 14 years of experience in the federal government. She was deputy director at the Medicare Payment Advisory Commission (MedPAC) and served at the Congressional Budget Office and the Centers for Medicare and Medicaid Services (CMS). Sarah has worked for national associations, in state government and for the Advisory Board Company. She holds an M.S. in Health Policy and Management from the Harvard School of Public Health.

Per Troein  
Per Troein, Vice President, Strategic Partners, IQVIA

Per Troein has been with IMS for 20 years and is responsible for supplier and associations relationships. He is a well-known speaker in the field of distribution trends and pricing and is very active in consulting projects in the area.

The dispensing and distribution environment is very dynamic. Pricing of pharmaceutical is as complicated. One of IMS’ priorities is to have the best understanding of those dynamics to secure the most appropriate data, to be the best partner with the different data partners, and to be able to support the industry and also, when appropriate, governments.

Prior to joining IMS, Per worked 13 years for Pharmacia. His last 6 years were spent in strategic development as a Vice President, including several major mergers and acquisitions.

He holds an MSc in engineering from Lund’s Institute of Technology and an MBA from INSEAD.

Stephen Truick  
Stephen Truick, Director, Internet Infrastructure Investigation Ltd

Stephen Truick is a consultant internet infrastructure investigator and the owner and director of Internet Infrastructure Investigation Ltd.

He is regarded as an innovator and industry / law enforcement expert in the field of Internet Infrastructure abuse. He was the officer in charge of the infrastructure abuse unit (Metropolitan Police), part of the National Police Central e-crime Unit (PCeU).

Upon leaving the police force, Stephen worked at the Medicines and Healthcare products Regulatory Agency (MHRA), where he led on Internet investigations including Operation Pangea, which is the global international week of action tackling the online sale of counterfeit and illicit medicines.

Stephen now works as a consultant with many well-known companies and specializes on the identification and disruption of online organized criminal networks who are abusing the U.K. domain space.

Fabian Vaucher  
Fabian Vaucher, President, pharmaSuisse (Swiss Association of Pharmacists)

Fabian Vaucher is the President of the Swiss Association of Pharmacists, pharmaSuisse, since 2015. Before this, he managed the Pharmacists’ Association of the Canton of Aargau. He is co-owner of two pharmacies and leads a quality circle physicians-pharmacists in the region of Aarau since 2001. Beginning this year, he also has been heading the Board of Directors of the new "Austrittsapotheke im Kantonsspital Aarau," which is run by 31 pharmacies in the greater area of Aarau.

Mr. Vaucher studied pharmacy in Basel and completed his training as a community pharmacist.